Canada Life’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Canada Life’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-6,207	Closed	-$110K	–	2805
2018 Q3	$110K	Hold	6,207	–	–	﹤0.01%	2161
2018 Q2	$86K	Buy	+6,207	New	+$73.7K	﹤0.01%	2239
2015 Q4	–	Sell	-18,500	Closed	-$85K	–	2476
2015 Q3	$85K	Buy	+18,500	New	+$96.8K	﹤0.01%	1825

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Canada Life's ECYT Position: Q4 2018 in Review

Canada Life sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 6,207 shares — an estimated $110K sold.

Canada Life first reported a position in ECYT in Q3 2015 and held it in 3 quarters. The position peaked at $110K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Canada Life reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Canada Life sold 6,207 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $110K.
Canada Life first reported a position in Endocyte, Inc. Common Stock in Q3 2015 and held it in 3 quarters.
Canada Life's Endocyte, Inc. Common Stock position peaked at $110K in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Canada Life's 13F filing for Q4 2018, filed 12 Feb 2019.